Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Cardiovasc Pathol. Author manuscript; available in PMC 2011 July 1.
Published in final edited form as:
PMCID: PMC3046386

Causes and histopathology of ascending aortic disease in children and young adults



Ascending aortic diseases (aneurysms, dissections, and stenosis) and associated aortic valve disease are rare but important causes of morbidity and mortality in children and young adults. Certain genetic causes, such as Marfan syndrome and congenital bicuspid aortic valve disease, are well known. However, other rarer genetic and nongenetic causes of aortic disease exist.


We performed an extensive literature search to identify known causes of ascending aortic pathology in children and young adults. We catalogued both aortic pathologies and other defining systemic features of these diseases.


We describe 17 predominantly genetic entities that have been associated with thoracic aortic disease in this age group.


While extensive literature on the common causes of ascending aortic disease exists, there is a need for better histologic documentation of aortic pathology in rarer diseases.

Keywords: Aortic aneurysm, Dissection, Genetic

1. Introduction

Ascending aortic disease can have devastating effects on affected individuals, resulting in severe morbidities including aneurysms, tears, dissections, hemopericardium, supra-valvular stenosis, and aortic valve regurgitation secondary to annular dilatation. While rare, it is an important cause of death in children and young adults. In the adult population, aneurysms have an estimated incidence of 5.9 cases per 100,000 person-years [1]. There are no data on the pediatric population, but aortic disease is expected to be less frequent. At our institution, a major referral center for genetic syndromes associated with aortic aneurysms, ascending aortic specimens from children and young adults represent less than 0.1% of the surgical pathology caseload. In the forensic setting, aortic dissections were found in 5.4% of autopsies performed for sudden cardiac deaths in young individuals [2].

Despite several recent large case studies that have evaluated the histopathology of the ascending aorta, the etiologies of most cases in young adults were unclassified [3,4]. Unlike aortic aneurysms in older adults that are associated with hypertension, smoking, and hypercholesterolemia, aneurysms in young individuals generally occur in the setting of an inherited disorder [5]. Yet, no studies have adequately correlated pathologic and clinical diagnoses in this population. Among genetic disorders, a common final aberration is an up-regulation of tumor growth factor (TGF) β activity in the ascending aorta. These “TGFβ-opathies” include Marfan syndrome (MFS), Loeys–Dietz syndrome (LDS), Ehlers–Danlos syndrome type IV (EDS-IV), arterial tortuosity syndrome (ATS), autosomal dominant polycystic kidney disease (ADPKD), and autosomal recessive cutis laxa type 1 (ARCL), which are described herein [68].

This review provides a description of the entities that can lead to ascending aortic disease in children and young adults to raise awareness on the causes of aortic dissection in this population. We have collected histopathologic descriptions of these entities (Table 1) and have documented known physical findings beyond the ascending aorta to best characterize each disease. As described herein, making a definitive disease diagnosis of an ascending aortic specimen is usually not possible on the basis of histopathology alone. However, histologic features, when correlated with clinical situations, can significantly narrow down the potential causes of the aneurysm/dissection. This can aid clinicians and geneticists in either treatment of the affected individual or counseling of the relatives of the affected individual. Finally, we recommend a handling–dissection strategy for aortic roots as surgical or autopsy tissues, so that maximal information may be gleaned from each case by the examining pathologist.

Table 1
Pathologic changes in the ascending aorta in diseases of children and young adults

2. Genetic causes of ascending aortic pathology

2.1. MFS

MFS, first described in 1896, is a genetic disorder caused by mutations in the fibrillin-1 (FBN1) gene (Table 2) [9]. The syndrome’s key phenotypic features are found in the cardiovascular, skeletal, and ocular systems (Table 3).

Table 2
Hereditary disorders affecting ascending aortas
Table 3
Systemic features of diseases causing aortic aneurysms

Cardiovascular disease is, by far, the most common cause of death in patients with MFS. Sixty-one percent of infants and children have a cardiac abnormality, with mitral regurgitation being the most commonly encountered lesion [10]. Aortic root dilatation and ascending aortic aneurysms are cardinal manifestations of the syndrome and predispose these individuals to a potentially fatal aortic dissection. Aortic root dilatation develops early in MFS and is present in 35% of individuals by the age of 5 years and in 68–80% of individuals by the age of 19 years [11].

On gross examination, ascending aortic specimens (when intact) are dilated but generally unremarkable. If seen on autopsy, they often have annuloaortic ectasia in which both the aortic annulus and the ascending aorta are enlarged and display a flask-like shape. The most common histopathologies of the aorta are elastic fiber fragmentation (EFF) and cystic medial degeneration (CMD) with glycosaminoglycan pools (Fig. 1, Table 1). The degree to which these histopathologic findings exist is highly variable, with some individuals (particularly those undergoing prophylactic resection) exhibiting no histologic abnormalities in their aortas.

Fig. 1
Histology of ascending aortas. (A) Normal ascending aorta showing dense elastic fibers in a young adult (Movat pentachrome, original magnification, ×10). (B) Ascending aorta with CMD and elastic fiber loss, characteristic of many genetic forms ...

2.2. LDS

LDS is a recently described disorder of connective tissues that shares some overlapping features with MFS and the vascular type of Ehlers–Danlos syndrome (EDS-IV), although several morphologic differences exist (Table 3). LDS is an autosomal dominant disorder caused by mutations in the transforming growth factor β receptor 1 (TGFBR1) or transforming growth factor β receptor 2 (TGFBR2) gene (Table 2). It has a more aggressive vascular pathology than MFS, with an aortic dissection rate approaching 70% of patients and with a median survival of only 37 years [12].

LDS is clinically classified into types 1 and 2 based on differences in the craniofacial system. LDS type 1 is characterized by craniofacial features including hypertelorism, craniosynostosis, and cleft palate. These individuals more typically have skeletal features that overlap with MFS. LDS type 2 may not present with these features, but can present with cutaneous features that overlap with EDS-IV (Table 3). Aortic aneurysms are common to both types; however, a more severe vascular phenotype is seen in subjects with LDS type 1 compared to those subjects with LDS type 2.

Cardiovascular lesions in LDS include aortic valvular regurgitation and aortic root dilation, aneurysm, and dissection. Aortic aneurysms in LDS subjects tend to be aggressive and to rupture at a smaller diameter than seen in MFS subjects. Thus, prophylactic replacement of the aortic root is recommended for patients with LDS [13].

The pathology of aortas in LDS is generally similar to that seen in MFS. In contrast to CMD, which is usually focally present in MFS, aortas from LDS patients have a more diffuse medial degeneration (DMD) (Table 1) [14]. This degeneration is characterized by fragmentation and/or loss of predominantly intralamellar elastic fibers, as opposed to CMD in which EFF is usually interlamellar (Fig. 1C and D). We have reported a significant correlation between histopathologic severity and echocardiographic Z-scores (age-adjusted measure of aortic diameter) of the aortic root [14].

2.3. ATS

ATS is an autosomal recessive disorder caused by mutations in the solute carrier family 2 member 10 (SLC2A10) gene that encodes for the glucose transporter GLUT10 (Table 2) [7].

Early in their lives, patients usually present with characteristic dysmorphic features: hyperextensible skin and joints (Table 3). Clinically, the disease overlaps with EDS-IV, but these subjects lack the structural collagen defect of EDS-IV [15]. Tortuosity of the aorta and large arteries is invariably present in ATS and often has a striking appearance on radiographic imaging. This is in comparison to tortuous vessels in LDS, where tortuosity is more variable in the presence of—and often confined to—neck or head vasculature. Nineteen to 31% of patients develop aortic aneurysms [16]. Although the exact mechanism is unknown, tortuosity may result in a higher shear stress that might predispose to arterial dissection [17]. Mortality due to stroke and arterial dissection is high in young patients, although a recent review indicates a less severe cardiovascular prognosis than once believed [16,18].

On gross examination, major vessels, including the aorta, appear thickened, elongated, and tortuous. The stretching and elongation of the great arteries in older persons are due primarily to loss of elasticity. Histopathology of affected vessel walls demonstrates fragmentation of the inner elastic membrane and fragmentation and loss of elastic fibers of the tunica media and external elastic membrane (Table 1). The intima is often markedly thickened due to fibrosis [15].

2.4. Bicuspid aortic valve

Bicuspid aortic valve (BAV) is the most common congenital heart abnormality, affecting up to 2% of the population [19]. Although mutations in NOTCH1 are associated with a subset of cases of BAV with characteristic aortic calcifications and variable aneurysm formation, the genetic basis of BAV is largely unknown (Table 2) [20]. Patients with BAV have variable expressions of additional cardiovascular pathologies, notably aortic aneurysm. Roughly 50% of young men with BAV have abnormal aortic dimensions consistent with aneurysms [21]. Approximately 5% of patients with BAV will develop an aortic dissection [22]. In contrast to MFS, patients with BAV do not have dilatation of the aortic sinuses [23].

Frequently, a normal media is described in patients with BAV [3]. When histopathologic changes are present, similar to those in MFS, the aortas of patients with BAV have CMD (Table 1) [24]. Patients with BAV have thinner elastic lamellae of the aortic media and greater distances between elastic lamellae than patients with tricuspid aortic valves [25].

2.5. Turner syndrome

Turner syndrome (TS) is a sex aneuploidy syndrome in which a single X chromosome is present (45,XO) (Table 2). The primary manifestations of TS are short stature, webbed neck, and infertility. Cardiovascular diseases are common and include congenital heart defects such as BAVs and a distinctive form of coarctation of the aorta, sometimes referred to as pseudocoarctation [26]. TS individuals have an elongation of the transverse aortic arch, with noticeable kinking in the juxtaductus region of the inferior curvature of the aortic arch [27]. Aortic dilation (or dissection) has been reported in conjunction with other cardiac anomalies (BAVs and coarctation) in ~1.5% of TS subjects [28].

Aortic dilation typically involves the root of the ascending aorta, occasionally extending through the aortic arch to the descending aorta [28]. Aortic dilations and dissections occur in young individuals with TS. In one study, over 65% of subjects with aortic dilation were less than 21 years of age [28]. In a review of aortic dissection cases, over half of patients were less than 30 years of age [29].

On histologic examination, CMD, similar to MFS, has been reported in TS (Table 1) [28].

2.6. EDS-IV

EDS is a rare inherited connective tissue disease with abnormal synthesis of collagens or related enzymes. EDS has been subdivided into six main types, with significant vascular manifestations being encountered in EDS-IV or vascular EDS. EDS-IV results from mutations in the collagen, type III, α-1 (COL3A) gene, which encodes for type III 1 collagen present in skin, vessel wall, and hollow organs (Table 2). Clinically, vascular EDS presents with characteristic facial features, thin skin, and rupture of vessels or viscera (Table 3) [30].

Arterial tears of the aorta and its branches are considered hallmarks of this disease. The true incidence of aortic dissection in these patients is not known; however, a review of 112 cases of EDS-IV noted that 10% of patients had an aortic dissection as part of their disease spectra [31]. In general, rupture and dissection outweigh aneurysm. Thoracic aortic aneurysms related to EDS-IV are rarely seen in childhood [32]. Patients have a 25% risk of experiencing a major vascular complication by the age of 20 years, and life expectancy is around 48 years [30]. EDS-IV patients have a low tolerance to surgery owing to the extreme fragility of their vascular wall, making them poor surgical candidates particularly in acute settings, in sharp contrast to patients with other aneurysm syndromes.

Histologic findings may be relatively subtle and nonspecific despite significant transmural tears in the aorta. Microscopic examination reveals minimal medial degeneration of the aortic wall with partial disruption of elastic laminae and intervening organized fibrous tissue (Table 1) [3,30].

EDS-IV is the one aortic disease in which ultrastructural examination by transmission electron microscopy is diagnostically valuable. These aortas have irregularities in the diameter of collagen fibers and an unidentified fibrinogranular substance within the extracellular matrix. However, due to the high number of false negatives, the absence of these features should not exclude the diagnosis of EDS-IV [33].

2.7. Homozygous familial hypercholesterolemia

Homozygous familial hypercholesterolemia (HFH) is an inherited metabolic disorder caused by mutations in the low-density lipoprotein receptor (LDLR) gene, leading to hypercholesterolemia and a predisposition to premature cardiovascular disease (Table 2). Children with HFH may have symptoms of coronary artery disease and aortic stenosis [34]. The aortic root is prone to developing atherosclerotic plaque at an early age in these individuals. HFH patients’ aortic roots have thicker walls and a reduced cross-sectional area compared to healthy controls [35]. Atheromatous involvement of the aortic root, rarely seen in heterozygotes, is almost always present in homozygotes and leads to aortic hypoplasia, supravalvular aortic stenosis, and, extremely rarely, to dissection [36]. Aortography shows characteristic aortic root funneling when the proximal ascending aorta is infiltrated by atheroma [37]. Aortic roots have less wall distensibility due to atheromatous plaque lesions [38].

On histologic examination, atheromatous plaques are observed around the supravalvular aortic ridge, just above the noncoronary cusp and ostia of both coronary arteries. Speckled plaques are spread above the ridge toward the ascending aorta for a few centimeters. The aortic root lesions consist of foam cells, cholesterol clefts, and fibrocalcific deposits (Table 1). The presence of intracellular lipid and cholesterol clefts within cuspal tissues is characteristic [37].

2.8. ADPKD

ADPKD is one of the most common hereditary disorders caused by mutations in the polycystic kidney disease (PKD) 1 gene (Table 2). Cardiovascular disease is a well-appreciated complication of ADPKD. Left ventricular hypertrophy and valvular incompetence are common features [39]. Saccular (berry) intracranial aneurysms are found in up to half of all patients with ADPKD and are prone to rupture [40]. Ruptured abdominal and/or thoracic aneurysms are also described, but may be the result of significant hypertension in this patient population. Thoracic aortic dissections are extremely rare but potentially fatal complications of this disease [41]. The histopathology of the excised aorta, when present, has been described as showing CMD (Table 1).

2.9. Noonan syndrome

Noonan syndrome (NS) is a relatively common autosomal dominant cardiofacial syndrome. The protein tyrosine phosphatase, nonreceptor type 11 (PTPN11) gene has been implicated as causing the majority of NS, although mutations in other genes in the RAS–MAPK pathway have also been described (Table 2) [42]. Cardiac defects occur in over 50% of patients. Cardiac disorders include dysplastic pulmonic valves, hypertrophic cardiomyopathy, and, less commonly, pulmonary artery stenosis, atrial septal defects, or patent ductus arteriosus (Table 3) [43]. The syndrome is associated with aneurysms of the sinuses of Valsalva and rarely with aortic dissection. Medial degeneration has been described in reported cases as a histologic finding suggesting defective connective tissue [44] (Table 1).

2.10. Tetralogy of Fallot (TOF)

TOF is a complex of anatomic abnormalities including pulmonary stenosis, ventricular septal defects, deviation of the aortic origin, and right ventricular hypertrophy. Although it is the most commonly encountered cyanotic congenital heart defect in infancy, insidious development of progressive aortic root dilatation has been seen in adult survivors who have undergone surgical repair [45]. The underlying pathophysiology of ascending aortic dilatation is unknown. In addition to previous long-standing volume overload, intrinsic histologic abnormalities in the aortic root and ascending aortic wall have been observed in various studies (Table 1) [46]. Abnormalities of smooth muscles, elastic fibers, collagen, and ground substance in the tunica media of the ascending aorta were found to be prevalent in these patients, predisposing to aortic dilatation, aneurysm, and/or aortic rupture [47].

2.11. Familial thoracic aortic aneurysm and dissection (FTAAD)

Up to 20% of patients referred for repair of thoracic aneurysm or dissection have familial clustering of the disease. Many of these families do not meet the clinical criteria for any of the abovementioned hereditary disorders. In most of these families, inheritance is autosomal dominant, with decreased penetrance and variable age-related onset of symptoms (Table 2) [48]. A number of different genetic mutations confer a variable constellation of additional phenotypes and can be associated with aortic dissections in mildly aneurysmal aortas (Table 3) [49]. Thus, further characterization and subclassification of this group are warranted.

On gross examination, aneurysms and dissections can occur anywhere along the ascending aorta and are not confined to the annulus. On histologic examination, in aortas from subjects harboring MYH11 and ACTA2 mutations, there is focal medial degeneration with disorganization of smooth muscle cells, elastic fiber loss, and increased penetrance of vaso vasorum into the medial layer [50,51].

2.12. Coarctation of the aorta

Coarctation of the aorta occurs in 5–10% of congenital heart disease. It is defined by a narrowing of the aorta just distal to the left subclavian artery or, more rarely, by narrowing proximal to the left subclavian artery. BAVs are frequently seen in conjunction with coarctation [52]. Coarctation has well-described clinical findings, including systolic murmur and high blood pressure in the upper extremities and low blood pressure with near-absent pulses in the lower extremities. While generally detected and treated with surgical repair in infancy, some cases of coarctation remain undiagnosed. Prior to the surgical era, coarctation frequently led to congestive heart failure and aortic dissection. Currently, coarctation is a rare cause of aortic dissection (Table 1) [53].

2.13. Autosomal recessive cutis laxa

ARCL is a rare disorder caused by mutations in the fibulin 5 (FBLN5) gene [54]. The disorder is characterized predominantly by loose, sagging skin from an early age (Table 3). These patients can have vascular diseases including fibromuscular dysplasia and pulmonary artery stenosis. Aortic aneurysm is a rarely reported complication. On histologic examination, one case report described degeneration of elastin, while a second case series identified a coarse outline of the elastic lamina in three subjects [55,56].

2.14. Shprintzen–Goldberg syndrome

Shprintzen–Goldberg syndrome (SGS) is a disorder of unknown etiology comprising Marfanoid features, craniosynostosis, and connective tissue abnormalities. Mutations in FBN1 have been described in this disorder, although at least one mutation was later found to be a polymorphism [57]. Only 23 subjects have been described with SGS through 2005 [58]. Among them, aortic dilation is an appreciated yet uncommon finding. Only a single report of aortic root dissection has been reported in the literature, and the histology of the aorta has not been described [59].

3. Nongenetic causes of ascending aortic disease

3.1. Aortitis

Ascending aortitis is characterized by the presence of inflammation of the adventitia and media, often with giant cells. It includes the diseases Takayasu arteritis (TA), giant cell arteritis (GCA), and isolated aortitis. GCA is generally described in patients older than 50 years of age and will not be described herein. The term “isolated aortitis” is used when patients have no clinical symptoms other than those related to aortic root disease [60].

TA is an inflammatory disease of unknown etiology that predominantly affects the aorta and its main branches [61]. The disease generally presents between the ages of 10 and 30 years, with a female/male ratio of 8.5:1 [62]. Although it is more common in Southeast Asian countries, cases are becoming increasingly recognized worldwide. Overall, the incidence of TA is two to three cases per million people.

On gross examination, the aorta is thick and often rigid secondary to transmural fibrosis. The aortic lumen is narrowed in a “skipped” area fashion and may alternate with aneurysmal dilatations. The intima has a cobblestone appearance, with multiple smooth and glistening plaques. Often a thick intima may reveal wrinkling and ridges and may give rise to a “tree bark” appearance, a feature common to many arteridities [63].

On histologic examination, there is an initial inflammatory response in the vaso vasorum, with cellular infiltration mainly by T cells (Table 1). Inflammation extends to the outer layer of the media and adjacent adventitia with a mixture of inflammatory cells, including plasma cells and macrophages [64]. In the media, there is a patchy heavy inflammatory infiltrate with giant cells that causes elastic fiber and smooth muscle cell loss and ultimate replacement by collagen. Endarteritis obliterans or onion-skin-type fibrosis can be present in the vasa vasorum [65]. If there is acute progression with destruction of the media, aneurysms may develop [64]. Aneurysms occur in up to 45% of patients, with the ascending aorta and the aortic arch being the frequent locations [66].

Burke et al. [67] proposed a histologic classification of noninfectious aortitis with two categories: necrotizing and nonnecrotizing. They proposed that the necrotizing form is an autoimmune condition that may be localized (isolated necrotizing aortitis) or may be part of a systemic autoimmune process. Infrequently, it may be a manifestation of TA, suggesting that there are other diseases that cause this histologic appearance.

3.2. Cocaine

Cocaine abuse leads to numerous cardiovascular complications. These include coronary artery vasoconstriction, myocardial infarction, arrhythmia, cardiomyopathy, and aortic dissection. Cocaine abuse causes catecholamine release and stimulation of α and β adrenergic receptors, which can result in vasoconstriction and spasm of anysized artery. Chronic cocaine abuse causes increased diastolic aortic diameter, loss of aortic elasticity, and increased aortic stiffness [68]. These chronic changes, coupled with other risk factors such as untreated hypertension and smoking, likely increase susceptibility to aortic dissections in a small minority of cocaine abusers. In one inner-city population, 37% of aortic dissections were the result of cocaine abuse, predominantly in young male hypertensive smokers [69]. Conversely, cocaine abuse has only been associated with 0.5% of cases in the International Registry of Aortic Dissection, indicating that, with the exception of selected populations, it is a rare cause of dissection [70].

On histologic examination, CMD has been described in a subject with dissection, suggesting the potential for an underlying aortic pathology (Table 1) [71].

3.3. Weightlifting and severe physical exertion

Weightlifting and severe physical exertion have been described as causes of aortic dissections. Recently, 31 patients who developed acute aortic dissection in the context of severe physical exertion were described [72]. Affected subjects ranged in age from 19 to 76 years of age, with a strong male predominance (30:1). Most of these subjects had moderately enlarged aortas (4–5 cm in diameter). Less than 10% of subjects had a family history of aortic disease. The etiology of this dissection appears to be a rapid and dramatic elevation of blood pressure during extreme exertion against a mildly dilated aorta. On histologic examination, CMD was described in a few cases, suggesting the possibility of an underlying condition predisposing to the dissection [71].

3.4. Handling of specimens

For maximization of one’s ability to generate a meaningful diagnosis on aortic tissues, certain methods should be used. Ascending aortic specimens will be encountered either as general surgery specimens or on autopsy. Surgical specimens are either obtained from subjects with aortic root dilatation undergoing prophylactic replacement or obtained from subjects with aortic dissection undergoing emergent repair/replacement.

Aortic surgical specimens generally arrive fragmented or complete, in formalin or in saline, depending on the style of a given institution. Aortic tissue should be oriented and measured, and gross photographs should be taken if such facilities exist (Fig. 2). If a complete ring of aorta is available, the diameter should be measured. Tissue should be examined for evidence of dissection or intimal tears. The presence of atherosclerotic plaques, intimal thickening, evidence of prior surgery, and/or thrombus material should be commented upon. If there is significant calcification of the vessel, the use of a decalcifying agent would be appropriate before sectioning. A small piece of aortic media should be placed in glutaraldehyde for ultrastructural examination if EDS-IV is included in the differential diagnosis.

Fig. 2
Proper ascending aortic evaluation. (A) If intact, the diameter (d) of the aorta should be recorded. (B) Additional measures of size (h=height) and other pertinent findings should be noted. (C) Six sections of the aorta, fitting into two tissue cassettes, ...

For histology, full-thickness sections should be taken perpendicular to the luminal surface. A minimum of six sections, which can be placed in two cassettes, should be taken [3]. A complete histologic analysis should always include a hematoxylin–eosin slide and an elastic stain (Verhoeff’s Van Gieson stain, Movat pentachrome, or a similar stain) to evaluate EFF. A collagen stain (Masson trichrome) and an Alcian blue periodic acid Schiff stain are useful in detecting scarring and accumulation of collagen, proteoglycans, and mucopolysaccharides. Immunohistochemical stains for inflammatory markers (CD68, CD3, CD20, and CD138) can be obtained, as appropriate, when inflammatory cells are detected by hematoxylin–eosin. The presence of the findings described in Table 1 should be reported for each specimen, as appropriate.

As with any autopsy, careful external examination of the body is essential for delineating genetic causes of ascending aortic dissection. A recent study describes a useful autopsy checklist for evaluation of physical findings in subjects with thoracic aortic aneurysms [73]. Upon removal of the chest plate, careful examination of the chest cavity will determine if there is a hemothorax or a hemopericardium. If blood is found, the amount should be documented, and a careful search of the aorta should be performed in situ to identify the source of bleeding. Gross photographs should be taken. The chest block should be removed, with the thoracic aorta left attached to the heart. If the ascending aorta is aneurysmal, its diameter, length, and general shape should be documented. The aorta should then be removed at the level of the aortic valve, and the ascending aorta can be opened longitudinally opposite any gross pathology (tears and dissections). The specimen should then be cut and evaluated for histology as in the protocol for surgical specimens described above.

4. Conclusion

As can be noted from this review, the causes of ascending aortic aneurysm/dissection in children and young adults are varied, with inherited syndromes being the predominant causes of aortic disease in this age group. While no histologic features are sensitive to and specific for a particular etiology, the patterns of findings in a given case in which a particular diagnosis has not been rendered can help the pathologist suggest a direction for genetic follow-up. Despite the thoroughness of our search to identify cases of these entities with described histopathology, for most rare diseases, there are only scattered case reports without formal histologic analysis. Furthermore, the terminology for describing the histology is inconsistent, allowing for a range of interpretations of reported findings. Therefore, it is difficult to make any definitive conclusions about the range of histopathology of the rare causes of aortic aneurysms and dissections. This review therefore identifies gaps in our knowledge of ascending aortic disease and should be a starting point for more thoughtful and in-depth histomorphometric and immunohistochemical analyses of diseases of the ascending aorta.


The authors thank Jon Cristofersen and Norman Barker for their assistance with the images.


Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.


1. Bickerstaff LK, Pairolero PC, Hollier LH, et al. Thoracic aortic aneurysms: a population-based study. Surgery. 1982;92:1103–8. [PubMed]
2. Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young. Heart Rhythm. 2005;2:1277–82. [PubMed]
3. Homme JL, Aubry MC, Edwards WD, et al. Surgical pathology of the ascending aorta: a clinicopathologic study of 513 cases. Am J Surg Pathol. 2006;30:1159–68. [PubMed]
4. Nesi G, Anichini C, Tozzini S, Boddi V, Calamai G, Gori F. Pathology of the thoracic aorta: a morphologic review of 338 surgical specimens over a 7-year period. Cardiovasc Pathol. 2009;18:134–9. [PubMed]
5. Reed D, Reed C, Stemmermann G, Hayashi T. Are aortic aneurysms caused by atherosclerosis? Circulation. 1992;85:205–11. [PubMed]
6. Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005;37:275–81. [PubMed]
7. Coucke PJ, Willaert A, Wessels MW, et al. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet. 2006;38:452–7. [PubMed]
8. Gomez D, Al Haj Zen A, Borges LF, et al. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway. J Pathol. 2009;218:131–42. [PubMed]
9. Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337–9. [PubMed]
10. Phornphutkul C, Rosenthal A, Nadas AS. Cardiac manifestations of Marfan syndrome in infancy and childhood. Circulation. 1973;47:587–96. [PubMed]
11. van Karnebeek CD, Naeff MS, Mulder BJ, Hennekam RC, Offringa M. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child. 2001;84:129–37. [PMC free article] [PubMed]
12. Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355:788–98. [PubMed]
13. Williams JA, Loeys BL, Nwakanma LU, et al. Early surgical experience with Loeys–Dietz: a new syndrome of aggressive thoracic aortic aneurysm disease. Ann Thorac Surg. 2007;83:S757–90. [PubMed]
14. Maleszewski JJ, Miller DV, Lu J, Dietz HC, Halushka MK. Histopathologic findings in ascending aortas from individuals with Loeys–Dietz syndrome (LDS) Am J Surg Pathol. 2008;33:194–201. [PubMed]
15. Franceschini P, Guala A, Licata D, Di Cara G, Franceschini D. Arterial tortuosity syndrome. Am J Med Genet. 2000;91:141–3. [PubMed]
16. Wessels MW, Catsman-Berrevoets CE, Mancini GM, et al. Three new families with arterial tortuosity syndrome. Am J Med Genet A. 2004;131:134–43. [PubMed]
17. Golomb MR, Fullerton HJ. Kinky vessels and double joints: useful clues for childhood stroke? Neurology. 2006;67:199–200. [PubMed]
18. Roberts WC. The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol. 1970;26:72–83. [PubMed]
19. McKellar SH, Tester DJ, Yagubyan M, Majumdar R, Ackerman MJ, Sundt TM. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 2007;134:290–6. [PubMed]
20. Nistri S, Sorbo MD, Marin M, Palisi M, Scognamiglio R, Thiene G. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart. 1999;82:19–22. [PMC free article] [PubMed]
21. Borger MA, David TE. Management of the valve and ascending aorta in adults with bicuspid aortic valve disease. Semin Thorac Cardiovasc Surg. 2005;17:143–7. [PubMed]
22. Warren AE, Boyd ML, O’Connell C, Dodds L. Dilatation of the ascending aorta in paediatric patients with bicuspid aortic valve: frequency, rate of progression and risk factors. Heart. 2006;92:1496–500. [PMC free article] [PubMed]
23. de Sa M, Moshkovitz Y, Butany J, David TE. Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: clinical relevance to the Ross procedure. J Thorac Cardiovasc Surg. 1999;118:588–94. [PubMed]
24. Bauer M, Bauer U, Siniawski H, Hetzer R. Differences in clinical manifestations in patients with bicuspid and tricuspid aortic valves undergoing surgery of the aortic valve and/or ascending aorta. Thorac Cardiovasc Surg. 2007;55:485–90. [PubMed]
25. Bauer M, Pasic M, Meyer R, et al. Morphometric analysis of aortic media in patients with bicuspid and tricuspid aortic valve. Ann Thorac Surg. 2002;74:58–62. [PubMed]
26. Gotzsche CO, Krag-Olsen B, Nielsen J, Sorensen KE, Kristensen BO. Prevalence of cardiovascular malformations and association with karyotypes in Turner’s syndrome. Arch Dis Child. 1994;71:433–6. [PMC free article] [PubMed]
27. Ho VB, Bakalov VK, Cooley M, et al. Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation. 2004;110:1694–700. [PubMed]
28. Lin AE, Lippe B, Rosenfeld RG. Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics. 1998;e12:102. [PubMed]
29. Carlson M, Silberbach M. Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature. J Med Genet. 2007;44:745–9. [PMC free article] [PubMed]
30. Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers–Danlos syndrome type IV, the vascular type. N Engl J Med. 2000;342:673–80. [PubMed]
31. Bergqvist D. Ehlers–Danlos type IV syndrome. A review from a vascular surgical point of view. Eur J Surg. 1996;162:163–70. [PubMed]
32. Sarkar R, Coran AG, Cilley RE, Lindenauer SM, Stanley JC. Arterial aneurysms in children: clinicopathologic classification. J Vasc Surg. 1991;13:47–57. [PubMed]
33. Germain DP, Herrera-Guzman Y. Vascular Ehlers–Danlos syndrome. Ann Genet. 2004;47:1–9. [PubMed]
34. Haitas B, Baker SG, Meyer TE, Joffe BI, Seftel HC. Natural history and cardiac manifestations of homozygous familial hypercholesterolaemia. Q J Med. 1990;76:731–40. [PubMed]
35. Summers RM, Andrasko-Bourgeois J, Feuerstein IM, et al. Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia. Circulation. 1998;98:509–18. [PubMed]
36. Bory M, Donnarel G, Djiane P, Dor V, Serradimigni A. Aortic dissection ruptured into the pulmonary artery in a patient with familial hypercholesterolemia. Arch Mal Coeur Vaiss. 1970;63:1197–204. [PubMed]
37. Rallidis L, Naoumova RP, Thompson GR, Nihoyannopoulos P. Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia. Heart. 1998;80:583–90. [PMC free article] [PubMed]
38. Kawaguchi A, Miyatake K, Yutani C, et al. Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia. Am Heart J. 1999;137:410–8. [PubMed]
39. Handa SP. Cardiovascular manifestations of autosomal dominant polycystic kidney disease in young adults. Clin Invest Med. 2006;29:339–46. [PubMed]
40. Schievink WI, Torres VE, Piepgras DG, Wiebers DO. Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1992;3:88–95. [PubMed]
41. Lee CC, Chang WT, Fang CC, Tsai IL, Chen WJ. Sudden death caused by dissecting thoracic aortic aneurysm in a patient with autosomal dominant polycystic kidney disease. Resuscitation. 2004;63:93–6. [PubMed]
42. Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29:465–8. [PubMed]
43. Burch M, Sharland M, Shinebourne E, Smith G, Patton M, McKenna W. Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients. J Am Coll Cardiol. 1993;22:1189–92. [PubMed]
44. Purnell R, Williams I, Von Oppell U, Wood A. Giant aneurysms of the sinuses of Valsalva and aortic regurgitation in a patient with Noonan’s syndrome. Eur J Cardiothorac Surg. 2005;28:346–8. [PubMed]
45. Niwa K, Siu SC, Webb GD, Gatzoulis MA. Progressive aortic root dilatation in adults late after repair of tetralogy of Fallot. Circulation. 2002;106:1374–8. [PubMed]
46. Tan JL, Davlouros PA, McCarthy KP, Gatzoulis MA, Ho SY. Intrinsic histological abnormalities of aortic root and ascending aorta in tetralogy of Fallot: evidence of causative mechanism for aortic dilatation and aortopathy. Circulation. 2005;112:961–8. [PubMed]
47. Chowdhury UK, Mishra AK, Ray R, Kalaivani M, Reddy SM, Venugopal P. Histopathologic changes in ascending aorta and risk factors related to histopathologic conditions and aortic dilatation in patients with tetralogy of Fallot. J Thorac Cardiovasc Surg. 2008;135:69–77. [PubMed]
48. Milewicz DM, Guo DC, Tran-Fadulu V, et al. Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet. 2008;9:283–302. [PubMed]
49. LeMaire SA, Pannu H, Tran-Fadulu V, Carter SA, Coselli JS, Milewicz DM. Severe aortic and arterial aneurysms associated with a TGFBR2 mutation. Nat Clin Pract Cardiovasc Med. 2007;4:167–71. [PMC free article] [PubMed]
50. Pannu H, Tran-Fadulu V, Papke CL, et al. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet. 2007;16:2453–62. [PMC free article] [PubMed]
51. Guo DC, Pannu H, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet. 2007;39:1488–93. [PubMed]
52. Nihoyannopoulos P, Karas S, Sapsford RN, Hallidie-Smith K, Foale R. Accuracy of two-dimensional echocardiography in the diagnosis of aortic arch obstruction. J Am Coll Cardiol. 1987;10:1072–7. [PubMed]
53. Lynch MJ, Woodford NW, Dodd MJ. Sudden death due to aortic rupture complicating undiagnosed coarctation of the aorta in a teenager —a case report and review of the literature. J Forensic Leg Med. 2008;15:443–6. [PubMed]
54. Loeys B, Van Maldergem L, Mortier G, et al. Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet. 2002;11:2113–8. [PubMed]
55. Tsuji A, Yanai J, Miura T, et al. Vascular abnormalities in congenital cutis laxa—report of two cases. Acta Paediatr Jpn. 1990;32:155–61. [PubMed]
56. Mehregan AH, Lee SC, Nabai H. Cutis laxa (generalized elastolysis). A report of four cases with autopsy findings. J Cutan Pathol. 1978;5:116–26. [PubMed]
57. Sood S, Eldadah ZA, Krause WL, McIntosh I, Dietz HC. Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen–Goldberg) syndrome. Nat Genet. 1996;12:209–11. [PubMed]
58. Robinson PN, Neumann LM, Demuth S, et al. Shprintzen–Goldberg syndrome: fourteen new patients and a clinical analysis. Am J Med Genet A. 2005;135:251–62. [PubMed]
59. Furlong J, Kurczynski TW, Hennessy JR. New Marfanoid syndrome with craniosynostosis. Am J Med Genet. 1987;26:599–604. [PubMed]
60. Tavora F, Burke A. Review of isolated ascending aortitis: differential diagnosis, including syphilitic, Takayasu’s and giant cell aortitis. Pathology. 2006;38:302–8. [PubMed]
61. Miller DV, Isotalo PA, Weyand CM, Edwards WD, Aubry MC, Tazelaar HD. Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol. 2006;30:1150–8. [PubMed]
62. Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu’s arteritis. Clinical study of 107 cases. Am Heart J. 1977;93:94–103. [PubMed]
63. Gravanis MB. Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors. Int J Cardiol. 2000;75(Suppl 1):S21–36. [PubMed]
64. Noris M. Pathogenesis of Takayasu’s arteritis. J Nephrol. 2001;14:506–13. [PubMed]
65. Tann OR, Tulloh RM, Hamilton MC. Takayasu’s disease: a review. Cardiol Young. 2008;18:250–9. [PubMed]
66. Sueyoshi E, Sakamoto I, Hayashi K. Aortic aneurysms in patients with Takayasu’s arteritis: CT evaluation. AJR Am J Roentgenol. 2000;175:1727–33. [PubMed]
67. Burke AP, Tavora F, Narula N, Tomaszewski JE, Virmani R. Aortitis and ascending aortic aneurysm: description of 52 cases and proposal of a histologic classification. Hum Pathol. 2008;39:514–26. [PubMed]
68. Bigi MA, Aslani A, Mehrpour M. Effect of chronic cocaine abuse on the elastic properties of aorta. Echocardiography. 2008;25:308–11. [PubMed]
69. Hsue PY, Salinas CL, Bolger AF, Benowitz NL, Waters DD. Acute aortic dissection related to crack cocaine. Circulation. 2002;105:1592–5. [PubMed]
70. Eagle KA, Isselbacher EM, DeSanctis RW. Cocaine-related aortic dissection in perspective. Circulation. 2002;105:1529–30. [PubMed]
71. Hatzaras I, Tranquilli M, Coady M, Barrett PM, Bible J, Elefteriades JA. Weight lifting and aortic dissection: more evidence for a connection. Cardiology. 2007;107:103–6. [PubMed]
72. Simons AJ, Arazoza E, Hare CL, Smulyan H, Lighty GW, Parker FB. Circumferential aortic dissection in a young woman. Am Heart J. 1992;123(4 Pt 1):1077–9. [PubMed]
73. Ripperger T, Troger HD, Schmidtke J. The genetic message of a sudden, unexpected death due to thoracic aortic dissection. Forensic Sci Int. 2009;187:1–5. [PubMed]